European Commission Biotech Act regulatory sandbox

Country: Belgium

legislative-sandbox eu

Coverage

	CN	EU	US
regulatory-legal	✓	✓	✓

Regulatorsfdaefsanmpa

Verifiable facts

Fact	Value	Source
Affiliation	The European Commission's European Biotech Act proposal, which includes regulatory sandboxes, is a legislative initiative for the EU. Belgium is a prominent stakeholder in this process.	eur-lex.europa.eu · health.ec.europa.eu · eversheds-sutherland.com
Research focus	Health biotechnology, including advanced therapies, biologics, vaccines, diagnostics, AI-based biotechnology, and industrial/agricultural applications.	eur-lex.europa.eu · health.ec.europa.eu · raps.org
Facility	VIB.AI research labs (Leuven and Ghent), VIB Flow Cores (Ghent and Leuven), Bio-Incubator (Leuven).	health.ec.europa.eu · oxurion.com · vib.ai · vib.be
Grant	The EU proposes a Health Biotechnology Investment Pilot (linked to EIB Group) and an EU Late-Stage Capital Booster Pilot; funding under the European Competitiveness Fund (EUR 20.4 billion for 2028-2034). VIB receives competitive funding and base grants from the Flemish government.	eur-lex.europa.eu · health.ec.europa.eu · vib.be · iqvia.com
Publications	VIB reported 728 publications (2023). VIB.AI has 87 works.	vib.ai · vib.be
Principal staff	VIB Science directors include Diether Lambrechts and Bart Lambrecht.	vib.be · eu-openscreen.eu
Headcount	VIB hosts over 1,900 scientists; VIB.AI has approximately 66 researchers; Oxurion has engaged 17 members of personnel as of December 2024.	oxurion.com · vib.ai · vib.be

Independent sources: eu-openscreen.eu · eur-lex.europa.eu · eversheds-sutherland.com · health.ec.europa.eu · iqvia.com · oxurion.com · raps.org · vib.ai · vib.be

Technologies

Name	Cluster	Risk
Regulatory sandboxes for biotech	regulatory-legal	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.